Literature DB >> 27306633

Inflammatory demyelination without astrocyte loss in MOG antibody-positive NMOSD.

Justine J Wang1, Zane Jaunmuktane1, Catherine Mummery1, Sebastian Brandner1, Siobhan Leary1, S Anand Trip2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27306633      PMCID： PMC4940064          DOI： 10.1212/WNL.0000000000002844

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  7 in total

1.  Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody.

Authors:  Kensuke Ikeda; Naoki Kiyota; Hiroshi Kuroda; Douglas Kazutoshi Sato; Shuhei Nishiyama; Toshiyuki Takahashi; Tatsuro Misu; Ichiro Nakashima; Kazuo Fujihara; Masashi Aoki
Journal:  Mult Scler       Date:  2014-09-25       Impact factor: 6.312

2.  Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.

Authors:  Douglas Kazutoshi Sato; Dagoberto Callegaro; Marco Aurelio Lana-Peixoto; Patrick J Waters; Frederico M de Haidar Jorge; Toshiyuki Takahashi; Ichiro Nakashima; Samira Luisa Apostolos-Pereira; Natalia Talim; Renata Faria Simm; Angelina Maria Martins Lino; Tatsuro Misu; Maria Isabel Leite; Masashi Aoki; Kazuo Fujihara
Journal:  Neurology       Date:  2014-01-10       Impact factor: 9.910

3.  Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis.

Authors:  Sudarshini Ramanathan; Kristina Prelog; Elizabeth H Barnes; Esther M Tantsis; Stephen W Reddel; Andrew P D Henderson; Steve Vucic; Mark P Gorman; Leslie A Benson; Gulay Alper; Catherine J Riney; Michael Barnett; John D E Parratt; Todd A Hardy; Richard J Leventer; Vera Merheb; Margherita Nosadini; Victor S C Fung; Fabienne Brilot; Russell C Dale
Journal:  Mult Scler       Date:  2015-07-10       Impact factor: 6.312

4.  Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.

Authors:  Joanna Kitley; Patrick Waters; Mark Woodhall; M Isabel Leite; Andrew Murchison; Jithin George; Wilhelm Küker; Saleel Chandratre; Angela Vincent; Jacqueline Palace
Journal:  JAMA Neurol       Date:  2014-03       Impact factor: 18.302

5.  Histopathology and clinical course of MOG-antibody-associated encephalomyelitis.

Authors:  Melania Spadaro; Lisa Ann Gerdes; Marie C Mayer; Birgit Ertl-Wagner; Sarah Laurent; Markus Krumbholz; Constanze Breithaupt; Tobias Högen; Andreas Straube; Armin Giese; Reinhard Hohlfeld; Hans Lassmann; Edgar Meinl; Tania Kümpfel
Journal:  Ann Clin Transl Neurol       Date:  2015-01-14       Impact factor: 4.511

6.  International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Authors:  Dean M Wingerchuk; Brenda Banwell; Jeffrey L Bennett; Philippe Cabre; William Carroll; Tanuja Chitnis; Jérôme de Seze; Kazuo Fujihara; Benjamin Greenberg; Anu Jacob; Sven Jarius; Marco Lana-Peixoto; Michael Levy; Jack H Simon; Silvia Tenembaum; Anthony L Traboulsee; Patrick Waters; Kay E Wellik; Brian G Weinshenker
Journal:  Neurology       Date:  2015-06-19       Impact factor: 9.910

7.  Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica.

Authors:  Tatsuro Misu; Romana Höftberger; Kazuo Fujihara; Isabella Wimmer; Yoshiki Takai; Shuhei Nishiyama; Ichiro Nakashima; Hidehiko Konno; Monika Bradl; Ferenc Garzuly; Yasuto Itoyama; Masashi Aoki; Hans Lassmann
Journal:  Acta Neuropathol       Date:  2013-04-12       Impact factor: 17.088
  7 in total
  20 in total

Review 1.  Myelin oligodendrocyte glycoprotein antibodies in neurological disease.

Authors:  Markus Reindl; Patrick Waters
Journal:  Nat Rev Neurol       Date:  2019-02       Impact factor: 42.937

2.  Retinal Nerve Fiber Layer May Be Better Preserved in MOG-IgG versus AQP4-IgG Optic Neuritis: A Cohort Study.

Authors:  Hadas Stiebel-Kalish; Itay Lotan; Judith Brody; Gabriel Chodick; Omer Bialer; Romain Marignier; Michael Bach; Mark Andrew Hellmann
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

Review 3.  Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases.

Authors:  Patrick Peschl; Monika Bradl; Romana Höftberger; Thomas Berger; Markus Reindl
Journal:  Front Immunol       Date:  2017-05-08       Impact factor: 7.561

4.  ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reports.

Authors:  Peter Körtvélyessy; Markus Breu; Marc Pawlitzki; Imke Metz; Hans-Jochen Heinze; Mike Matzke; Christian Mawrin; Paulus Rommer; Gabor G Kovacs; Christian Mitter; Markus Reindl; Wolfgang Brück; Klaus-Peter Wandinger; Hans Lassmann; Romana Höftberger; Frank Leypoldt
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-03-14

Review 5.  Defining distinct features of anti-MOG antibody associated central nervous system demyelination.

Authors:  Martin S Weber; Tobias Derfuss; Imke Metz; Wolfgang Brück
Journal:  Ther Adv Neurol Disord       Date:  2018-03-29       Impact factor: 6.570

Review 6.  MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder.

Authors:  Giordani Rodrigues Dos Passos; Luana Michelli Oliveira; Bruna Klein da Costa; Samira Luisa Apostolos-Pereira; Dagoberto Callegaro; Kazuo Fujihara; Douglas Kazutoshi Sato
Journal:  Front Neurol       Date:  2018-04-04       Impact factor: 4.003

Review 7.  Mechanisms for lesion localization in neuromyelitis optica spectrum disorders.

Authors:  Monika Bradl; Markus Reindl; Hans Lassmann
Journal:  Curr Opin Neurol       Date:  2018-06       Impact factor: 5.710

Review 8.  Pediatric Neuromyelitis Optica Spectrum Disorders.

Authors:  Grace Y Gombolay; Tanuja Chitnis
Journal:  Curr Treat Options Neurol       Date:  2018-05-02       Impact factor: 3.972

9.  Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies.

Authors:  Haeng-Jin Lee; Boram Kim; Patrick Waters; Mark Woodhall; Sarosh Irani; Sohyun Ahn; Seong-Joon Kim; Sung-Min Kim
Journal:  J Neuroinflammation       Date:  2018-10-31       Impact factor: 8.322

10.  Brain structural alterations in MOG antibody diseases: a comparative study with AQP4 seropositive NMOSD and MS.

Authors:  Yunyun Duan; Zhizheng Zhuo; Haiqing Li; De-Cai Tian; Yuxin Li; Liqin Yang; Chenyang Gao; Tian Zhang; Xinghu Zhang; Fu-Dong Shi; Frederik Barkhof; Yaou Liu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-03-09       Impact factor: 10.154
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.